Search for: "Teva Pharmaceutical"
Results 261 - 280
of 1,423
Sort by Relevance
|
Sort by Date
15 May 2019, 5:27 am
Kluwer Patent blogger44 U.S. states filed a lawsuit last Friday accusing Teva Pharmaceuticals USA of conspiring illegally with 19 other drug companies to inflate drug prices – sometimes by more than 1,000 percent – and stifle competition for generic drugs. [read post]
14 May 2019, 11:24 am
Teva Pharm. [read post]
14 May 2019, 7:50 am
The complaint was filed in the District Court for the District of Connecticut and names Teva Pharmaceuticals along with 19 other companies and 15 individuals who are senior executives at the heart of the scandal. [read post]
13 May 2019, 1:45 pm
Enlarge / A Teva facility in France. [read post]
13 May 2019, 8:48 am
Ltd. was supplying the active ingredient valsartan—a widely used treatment for high blood pressure that is taken alone, as well as sold in combination with other cardiovascular drugs—for major pharmaceutical companies such as Teva Pharmaceutical Industries Ltd., the largest generic drug maker in the world. [read post]
13 May 2019, 8:48 am
Ltd. was supplying the active ingredient valsartan—a widely used treatment for high blood pressure that is taken alone, as well as sold in combination with other cardiovascular drugs—for major pharmaceutical companies such as Teva Pharmaceutical Industries Ltd., the largest generic drug maker in the world. [read post]
10 May 2019, 11:15 am
This week in Other Barks & Bites, IPWatchdog's IP news roundup: the House of Representatives passes drug patent legislation, while antitrust legislation targeting patent-related activities is introduced into the Senate and the Trump administration mandates pricing information for pharmaceutical ads; the Patent Trial and Appeal Board (PTAB) issues a pair of precedential decisions on cases with multiple petitions; the USPTO issues marijuana-related trademark guidelines and a notice… [read post]
6 May 2019, 9:58 pm
Noonan -- Last Friday, the Federal Circuit affirmed a decision by the District Court that Defendants Actavis LLC and Teva Pharmaceuticals did not show by clear and convincing evidence that the claims asserted by Endo Pharmaceuticals Inc. and Mallinckrodt LLC were obvious, in Endo Pharmaceuticals Inc. v. [read post]
30 Apr 2019, 7:22 am
Prior to 2017, Canada had been the only G7 nation not to provide patent term extension for pharmaceutical products and was pressured into adopting this by the EU. [read post]
28 Apr 2019, 7:45 am
In Janssen v Teva (2009) the Federal Circuit stated that mere plausibility does not suffice to meet this requirement, if it did then patents could be obtained for little more than “respectable guesses”. [read post]
19 Apr 2019, 5:58 am
Teva Pharmaceuticals USA, Inc. [read post]
18 Apr 2019, 1:57 pm
Teva Pharmaceuticals USA, Inc. [read post]
18 Apr 2019, 1:57 pm
Teva Pharmaceuticals USA, Inc. [read post]
15 Apr 2019, 9:23 pm
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals USA, Inc.... [read post]
15 Apr 2019, 6:09 am
Teva Pharmaceuticals USA Inc.: Allergan & SRMT Cert Petition Questions presented: Whether the Federal Circuit erred in this case, as it did in Acorda Therapeutics, Inc. v. [read post]
9 Apr 2019, 8:03 pm
Teva Pharmaceuticals USA, Inc., 395 F.3d 1364 (Fed. [read post]
8 Apr 2019, 9:59 pm
Noonan -- FiercePharma today reported sales rankings for the top 15 pharmaceutical companies in 2018, in comparison to 2017 sales. [read post]
2 Apr 2019, 3:46 pm
Pulse, Teva v. [read post]
1 Apr 2019, 9:59 pm
Teva Pharmaceuticals USA, Inc., the Federal Circuit reversed a decision by the U.S. [read post]
28 Mar 2019, 11:01 am
West-Ward Pharmaceuticals International Ltd, 887 F.3d 1117 (Fed. [read post]
